Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Johnson and Johnson
Daiichi Sankyo
Covington
Moodys
Mallinckrodt
QuintilesIMS
Express Scripts
Federal Trade Commission

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,383,611

« Back to Dashboard

Which drugs does patent 8,383,611 protect, and when does it expire?

Patent 8,383,611 protects OMNARIS and is included in one NDA.

This patent has forty-three patent family members in thirty-five countries.
Summary for Patent: 8,383,611
Title:Ciclesonide containing aqueous pharmaceutical composition
Abstract: The present invention provides an aqueous pharmaceutical composition containing ciclesonide and hydroxypropyl-methylcellulose, wherein the ciclesonide is dispersed in an aqueous medium in the form of solid particles. The composition is able to avoid variations in the concentrations of ciclesonide during production as well as avoid decreases in the recovery rate of ciclesonide.
Inventor(s): Nagano; Atsuhiro (Tokyo, JP), Nishibe; Yoshihisa (Yamaguchi, JP), Takanashi; Kazuya (Tokyo, JP)
Assignee: Nycomed GmbH (Constance, DE)
Application Number:10/110,632
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 8,383,611

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Astrazeneca Pharms OMNARIS ciclesonide SPRAY, METERED;NASAL 022004-001 Oct 20, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,383,611

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan11/298186Oct 20, 1999
PCT Information
PCT FiledOctober 20, 2000PCT Application Number:PCT/JP00/07351
PCT Publication Date:April 26, 2001PCT Publication Number: WO01/28563

International Patents Family Members for US Patent 8,383,611

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2388325 ➤ Sign Up
Germany 60011924 ➤ Sign Up
Denmark 1227817 ➤ Sign Up
Eurasian Patent Organization 200200383 ➤ Sign Up
Eurasian Patent Organization 005201 ➤ Sign Up
European Patent Office 1227817 ➤ Sign Up
Spain 2223595 ➤ Sign Up
Hong Kong 1051003 ➤ Sign Up
Croatia P20020345 ➤ Sign Up
Hungary 0203756 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Harvard Business School
Cantor Fitzgerald
Citi
Baxter
Deloitte
McKinsey
Cipla
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot